Does TOFACITINIB Cause Musculoskeletal stiffness? 7,354 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7,354 reports of Musculoskeletal stiffness have been filed in association with TOFACITINIB (XELJANZ XR). This represents 4.7% of all adverse event reports for TOFACITINIB.
7,354
Reports of Musculoskeletal stiffness with TOFACITINIB
4.7%
of all TOFACITINIB reports
1,205
Deaths
1,985
Hospitalizations
How Dangerous Is Musculoskeletal stiffness From TOFACITINIB?
Of the 7,354 reports, 1,205 (16.4%) resulted in death, 1,985 (27.0%) required hospitalization, and 1,493 (20.3%) were considered life-threatening.
Is Musculoskeletal stiffness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 7,354 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Musculoskeletal stiffness?
ADALIMUMAB (10,762)
METHOTREXATE (9,903)
ETANERCEPT (9,744)
TOCILIZUMAB (6,346)
RITUXIMAB (6,058)
LEFLUNOMIDE (6,031)
ABATACEPT (5,926)
SECUKINUMAB (5,655)
HYDROXYCHLOROQUINE (5,271)
SULFASALAZINE (5,154)
Which TOFACITINIB Alternatives Have Lower Musculoskeletal stiffness Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN